284 related articles for article (PubMed ID: 12435776)
1. Increased risk for hepatitis B-related liver cirrhosis in relatives of patients with hepatocellular carcinoma in northern Taiwan.
Yu MW; Chang HC; Chen PJ; Liu CJ; Liaw YF; Lin SM; Lee SD; Lin SC; Lin CL; Chen CJ
Int J Epidemiol; 2002 Oct; 31(5):1008-15. PubMed ID: 12435776
[TBL] [Abstract][Full Text] [Related]
2. Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis.
Chien J; Liu J; Lee MH; Jen CL; Batrla-Utermann R; Lu SN; Wang LY; You SL; Yang HI; Chen CJ
J Gastroenterol Hepatol; 2016 Dec; 31(12):1971-1977. PubMed ID: 27118149
[TBL] [Abstract][Full Text] [Related]
3. Replication of hepatitis B virus in first-degree relatives of patients with hepatocellular carcinoma.
Tai DI; Changchien CS; Hung CS; Chen CJ
Am J Trop Med Hyg; 1999 Nov; 61(5):716-9. PubMed ID: 10586900
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers.
Yu MW; Hsu FC; Sheen IS; Chu CM; Lin DY; Chen CJ; Liaw YF
Am J Epidemiol; 1997 Jun; 145(11):1039-47. PubMed ID: 9169913
[TBL] [Abstract][Full Text] [Related]
5. Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers.
Tseng TC; Liu CJ; Chen CL; Yang HC; Su TH; Wang CC; Yang WT; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
J Infect Dis; 2013 Aug; 208(4):584-93. PubMed ID: 23656977
[TBL] [Abstract][Full Text] [Related]
6. Clinical features of HBsAg seroclearance in hepatitis B virus carriers in South Korea: A retrospective longitudinal study.
Park YM; Lee SG
World J Gastroenterol; 2016 Nov; 22(44):9836-9843. PubMed ID: 27956808
[TBL] [Abstract][Full Text] [Related]
7. Natural history of chronic hepatitis B REVEALed.
Chen CJ; Yang HI
J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus transmission and hepatocarcinogenesis: a 9 year retrospective cohort of 13676 relatives with hepatocellular carcinoma.
Chen CH; Chen YY; Chen GH; Yang SS; Tang HS; Lin HH; Lin DY; Lo SK; Du JM; Chang TT; Chen SC; Liao LY; Kuo CH; Lin KC; Tai DI; Changchien CS; Chang WY; Sheu JC; Chen DS; Liaw YF; Sung JL
J Hepatol; 2004 Apr; 40(4):653-9. PubMed ID: 15030982
[TBL] [Abstract][Full Text] [Related]
9. Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis.
Yang HI; Tseng TC; Liu J; Lee MH; Liu CJ; Su TH; Batrla-Utermann R; Chan HL; Kao JH; Chen CJ
Clin Gastroenterol Hepatol; 2016 Mar; 14(3):461-468.e2. PubMed ID: 26598229
[TBL] [Abstract][Full Text] [Related]
10. Childhood hepatocellular carcinoma develops exclusively in hepatitis B surface antigen carriers in three decades in Taiwan. Report of 51 cases strongly associated with rapid development of liver cirrhosis.
Hsu HC; Wu MZ; Chang MH; Su IJ; Chen DS
J Hepatol; 1987 Dec; 5(3):260-7. PubMed ID: 2828461
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya.
Mwangi J; Gatei DG
East Afr Med J; 1993 Apr; 70(4 Suppl):34-6. PubMed ID: 8223308
[TBL] [Abstract][Full Text] [Related]
12. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
13. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of hepatitis B virus surface antigen mutants in Singapore patients with hepatocellular carcinoma and hepatitis B virus carriers negative for HBsAg but positive for anti-HBs and anti-HBc.
Oon CJ; Chen WN; Goh KT; Mesenas S; Ng HS; Chiang G; Tan C; Koh S; Teng SW; Toh I; Moh MC; Goo KS; Tan K; Leong AL; Tan GS
J Gastroenterol Hepatol; 2002 Dec; 17 Suppl():S491-6. PubMed ID: 12534784
[TBL] [Abstract][Full Text] [Related]
15. Factors determining the development of hepatocellular carcinoma in hepatitis B surface antigen carriers. A comparison between families with clusters and solitary cases.
Lok AS; Lai CL
Cancer; 1988 Apr; 61(7):1287-91. PubMed ID: 2830957
[TBL] [Abstract][Full Text] [Related]
16. [Considerations on familial clustering of liver cirrhosis and hepatocellular carcinoma].
Ohbayashi A
Gan To Kagaku Ryoho; 1982 May; 9(5):799-807. PubMed ID: 6307184
[TBL] [Abstract][Full Text] [Related]
17. Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives.
Yu MW; Chang HC; Liaw YF; Lin SM; Lee SD; Liu CJ; Chen PJ; Hsiao TJ; Lee PH; Chen CJ
J Natl Cancer Inst; 2000 Jul; 92(14):1159-64. PubMed ID: 10904089
[TBL] [Abstract][Full Text] [Related]
18. Chronic liver disease in Ethiopia: a clinical study with emphasis on identifying common causes.
Tsega E; Nordenfelt E; Hansson BG; Mengesha B; Lindberg J
Ethiop Med J; 1992 Apr; 30(2 Suppl):1-33. PubMed ID: 1319901
[TBL] [Abstract][Full Text] [Related]
19. Risk of hepatobiliary disease in adults with severe alpha 1-antitrypsin deficiency (PiZZ): is chronic viral hepatitis B or C an additional risk factor for cirrhosis and hepatocellular carcinoma?
Elzouki AN; Eriksson S
Eur J Gastroenterol Hepatol; 1996 Oct; 8(10):989-94. PubMed ID: 8930564
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
